Estudio comparativo, prospectivo y aleatorizado de piperacilina/tazobactam frente a ceftriaxona y ornidazol en el tratamiento de las infecciones de las vías biliares
Randomized, prospective and comparative clinical trial of piperacillin/tazobactam versus ceftriaxone plus ornidazole in the treatment of biliary tract infections
Josep Maria Sirventa,
, José Ignacio Rodríguezb, Isabel Rodrígueza, Miguel García-Oriab, Josep Roigb, Alfons Boneta
Autor para correspondencia
uci.jmsirvent@htrueta.scs.es
Correspondencia: Servicio de Medicina Intensiva. Hospital Universitari de Girona Doctor Josep Trueta. Avda. de França, s/n. 17007 Girona. España.
Correspondencia: Servicio de Medicina Intensiva. Hospital Universitari de Girona Doctor Josep Trueta. Avda. de França, s/n. 17007 Girona. España.
Leído
4657
Vecesse ha leído el artículo
1775
Total PDF
2882
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 13 | 13 |
| 2025 11 | 0 | 54 | 54 |
| 2025 10 | 0 | 44 | 44 |
| 2025 9 | 0 | 39 | 39 |
| 2025 8 | 0 | 48 | 48 |
| 2025 7 | 0 | 38 | 38 |
| 2025 6 | 0 | 29 | 29 |
| 2025 5 | 0 | 46 | 46 |
| 2025 4 | 0 | 52 | 52 |
| 2025 3 | 0 | 44 | 44 |
| 2025 2 | 0 | 66 | 66 |
| 2025 1 | 0 | 39 | 39 |
| 2024 12 | 0 | 45 | 45 |
| 2024 11 | 0 | 32 | 32 |
| 2024 10 | 0 | 35 | 35 |
| 2024 9 | 5 | 32 | 37 |
| 2024 8 | 0 | 29 | 29 |
| 2024 7 | 0 | 34 | 34 |
| 2024 6 | 0 | 37 | 37 |
| 2024 5 | 0 | 31 | 31 |
| 2024 4 | 0 | 21 | 21 |
| 2024 3 | 0 | 44 | 44 |
| 2024 2 | 0 | 36 | 36 |
| 2024 1 | 0 | 43 | 43 |
| 2023 12 | 0 | 12 | 12 |
| 2023 11 | 0 | 18 | 18 |
| 2023 10 | 1 | 15 | 16 |
| 2023 9 | 0 | 2 | 2 |
| 2023 8 | 0 | 13 | 13 |
| 2023 7 | 1 | 34 | 35 |
| 2023 6 | 0 | 1 | 1 |
| 2023 5 | 0 | 1 | 1 |
| 2023 4 | 0 | 1 | 1 |
| 2023 3 | 2 | 4 | 6 |
| 2023 2 | 0 | 4 | 4 |
| 2022 1 | 0 | 2 | 2 |
| 2022 12 | 0 | 4 | 4 |
| 2022 11 | 0 | 1 | 1 |
| 2022 10 | 0 | 4 | 4 |
| 2022 9 | 0 | 9 | 9 |
| 2022 7 | 0 | 4 | 4 |
| 2022 6 | 0 | 3 | 3 |
| 2022 5 | 0 | 5 | 5 |
| 2022 3 | 0 | 2 | 2 |
| 2021 1 | 0 | 4 | 4 |
| 2021 12 | 0 | 8 | 8 |
| 2021 11 | 0 | 19 | 19 |
| 2021 7 | 0 | 2 | 2 |
| 2021 5 | 0 | 4 | 4 |
| 2021 4 | 0 | 2 | 2 |
| 2021 3 | 0 | 2 | 2 |
| 2021 2 | 0 | 2 | 2 |
| 2020 12 | 0 | 2 | 2 |
| 2020 10 | 0 | 1 | 1 |
| 2020 8 | 0 | 6 | 6 |
| 2020 7 | 0 | 2 | 2 |
| 2020 6 | 0 | 1 | 1 |
| 2020 4 | 0 | 4 | 4 |
| 2020 3 | 0 | 2 | 2 |
| 2020 2 | 0 | 4 | 4 |
| 2020 1 | 0 | 1 | 1 |
| 2019 12 | 0 | 12 | 12 |
| 2019 11 | 0 | 7 | 7 |
| 2019 10 | 0 | 7 | 7 |
| 2019 9 | 0 | 5 | 5 |
| 2019 8 | 0 | 6 | 6 |
| 2019 7 | 0 | 5 | 5 |
| 2019 6 | 0 | 2 | 2 |
| 2019 5 | 0 | 35 | 35 |
| 2019 4 | 0 | 16 | 16 |
| 2019 3 | 0 | 2 | 2 |
| 2019 2 | 0 | 8 | 8 |
| 2018 12 | 0 | 6 | 6 |
| 2018 11 | 0 | 5 | 5 |
| 2018 10 | 0 | 5 | 5 |
| 2017 10 | 5 | 14 | 19 |
| 2017 9 | 9 | 12 | 21 |
| 2017 8 | 11 | 25 | 36 |
| 2017 7 | 12 | 20 | 32 |
| 2017 6 | 16 | 15 | 31 |
| 2017 5 | 11 | 21 | 32 |
| 2017 4 | 10 | 15 | 25 |
| 2017 3 | 15 | 37 | 52 |
| 2017 2 | 18 | 8 | 26 |
| 2016 1 | 18 | 4 | 22 |
| 2016 12 | 34 | 12 | 46 |
| 2016 11 | 62 | 19 | 81 |
| 2016 10 | 69 | 9 | 78 |
| 2016 9 | 35 | 4 | 39 |
| 2016 8 | 29 | 4 | 33 |
| 2016 7 | 22 | 1 | 23 |
| 2016 6 | 51 | 14 | 65 |
| 2016 5 | 58 | 24 | 82 |
| 2016 4 | 60 | 13 | 73 |
| 2016 3 | 47 | 23 | 70 |
| 2016 2 | 30 | 20 | 50 |
| 2015 1 | 33 | 11 | 44 |
| 2015 12 | 38 | 13 | 51 |
| 2015 11 | 54 | 14 | 68 |
| 2015 10 | 66 | 11 | 77 |
| 2015 9 | 57 | 13 | 70 |
| 2015 8 | 52 | 9 | 61 |
| 2015 7 | 75 | 12 | 87 |
| 2015 6 | 33 | 7 | 40 |
| 2015 5 | 62 | 10 | 72 |
| 2015 4 | 85 | 14 | 99 |
| 2015 3 | 92 | 4 | 96 |
| 2015 2 | 64 | 14 | 78 |
| 2015 1 | 33 | 6 | 39 |
| 2014 12 | 62 | 7 | 69 |
| 2014 11 | 44 | 2 | 46 |
| 2014 10 | 69 | 2 | 71 |
| 2014 9 | 50 | 3 | 53 |
| 2014 8 | 31 | 1 | 32 |
| 2014 7 | 40 | 4 | 44 |
| 2014 6 | 36 | 3 | 39 |
| 2014 5 | 31 | 4 | 35 |
| 2014 4 | 21 | 2 | 23 |
| 2014 3 | 29 | 2 | 31 |
| 2014 2 | 20 | 2 | 22 |
| 2014 1 | 28 | 2 | 30 |
| 2013 12 | 40 | 2 | 42 |
| 2013 11 | 29 | 7 | 36 |
| 2013 10 | 49 | 7 | 56 |
| 2013 9 | 21 | 5 | 26 |
| 2013 8 | 24 | 8 | 32 |
| 2013 7 | 27 | 3 | 30 |
| 2013 5 | 1 | 0 | 1 |
| 2003 12 | 855 | 0 | 855 |
Mostrar todo
